Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports

We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).

Detalles Bibliográficos
Autores principales: Goodyer, Matthew J, Ismail, Jeffri RM, O'Reilly, Seamus P, Moylan, Eugene J, Ryan, C Anthony M, Hughes, Paul AF, O'Connor, Alan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803989/
https://www.ncbi.nlm.nih.gov/pubmed/20062589
http://dx.doi.org/10.1186/1757-1626-2-9329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803989/
https://www.ncbi.nlm.nih.gov/pubmed/20062589
http://dx.doi.org/10.1186/1757-1626-2-9329

Ejemplares similares